References
- The Michael J [Internet]. Fox Foundation: Parkinson's Disease Causes. [cited 2019 Feb 7]. Available from: https://www.michaeljfox.org/understandingparkinsons/living-with-pd/topic.php?causes&navid=causes.
- Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Felice A. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2017;64:666-672. https://doi.org/10.1136/oem.2006.027003
- Braak H, Del Tredici K, Rub U, de Vos RA, Steur EN J, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. https://doi.org/10.1016/S0197-4580(02)00065-9
- Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 2010;25:2493-2500. https://doi.org/10.1002/mds.23394
- Khedr EM, El Fetoh NA, Khalifa H, Ahmed MA, El Beh KMA. Prevalence of non motor features in a cohort of Parkinson's disease patients. Clin Neurol Neurosurg 2013;115:673-677. https://doi.org/10.1016/j.clineuro.2012.07.032
- Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP et al. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectional DoPAMiP study. Mov Disord 2010;25:157-166. https://doi.org/10.1002/mds.22760
- Degardin A, Houdayer E, Bourriez JL, Destee A, Defebvre L, Derambure P et al. Deficient "sensory" beta synchronization in Parkinson's disease. Clin Neurophysiol 2009;120:636-642. https://doi.org/10.1016/j.clinph.2009.01.001
- Schulte EC, Winkelmann J, When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease. J Neurol 2011;258:328-335. https://doi.org/10.1007/s00415-011-5933-0
- Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013;80:276-281. https://doi.org/10.1212/WNL.0b013e31827deb74
- Oh Y-S, Kim JS, Hwang EJ, Lyoo CH. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease. Parkinsonism Relat Disord 2018;56:47-51. https://doi.org/10.1016/j.parkreldis.2018.06.022
- Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? QJM 1999;92:473-480. https://doi.org/10.1093/qjmed/92.8.473
- Munhoz PR, Moro LA, Silveira-Moriyama L, Teive HA. Non-motor signs in Parkinson's disease: A review. Arq Neuropsiquiatr 2015;73:454-462. https://doi.org/10.1590/0004-282X20150029
- Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurosci 2008;255:1121-1126.
- Lin T, Cheng C, Chen S, Liou C, Huang C, Chuang Y. Mitochondrial Dysfunction and Oxidative Stress Promote Apoptotic Cell Death in the Striatum via Cytochrome c/Caspase-3 Signaling Cascade Following Chronic Rotenone Intoxication in Rats. Int J Mol Sci 2012;13:8722-8739. https://doi.org/10.3390/ijms13078722
- Vickers AJ. How to randomize. J Soc Integr Oncol 2006;4:194-198. https://doi.org/10.2310/7200.2006.023
- True Random Number Service [Internet]. 2019. Available from: https://www.random.org/.
- The R Foundation [Internet]. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. Available from: https://www.R-project.org/.
- Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 2010;35:129-150. https://doi.org/10.1016/j.neubiorev.2010.02.001
- Iannilli E, Stephan L, Hummel T, Reichmann H, Haehner A. Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline. J Neurol 2017; 264: 1236-1246. https://doi.org/10.1007/s00415-017-8521-0
- Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg 2001;127:497-503. https://doi.org/10.1001/archotol.127.5.497
- Soudry Y, Lemogne C, Malinvaud D, Consoli SM, Bonfils P. Olfactory system and emotion: Common substrates. Eur Ann Otorhinolaryngol Head Neck Dis 2011;128:18-23. https://doi.org/10.1016/j.anorl.2010.09.007
- Rochet M, El-Hage W, Richa S, Kazour F, Atanasova B. Depression, Olfaction, and Quality of Life: A Mutual Relationship. Brain Sci 2018;8:80. https://doi.org/10.3390/brainsci8050080
- Fullard ME, Morley JF, Duda JE. Olfactory dysfunction as an early biomarker in Parkinson's disease. Neurosci Bull 2017;33:515-525. https://doi.org/10.1007/s12264-017-0170-x
- Hong JY, Sunwoo MK, Ham JH, Lee JJ, Lee PH, Sohn YH. Apathy and olfactory dysfunction in early Parkinson's disease. J Mov Disord 2015;8:21-25. https://doi.org/10.14802/jmd.14029
- Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53:26-38. https://doi.org/10.1002/ana.10483
- Crotty GF, Ascherio A, Schwarzschild MA. Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol 2017;298:210-224. https://doi.org/10.1016/j.expneurol.2017.06.017
- Asanuma M, Miyazaki I, Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003;5:165-176. https://doi.org/10.1007/BF03033137
- Zhang L, Zhang L, Li L, Holscher C. Semaglutide is neuroprotective and reduces a-synuclein levels in the chronic MPTP mouse model of Parkinson's disease. J Parkinsons Dis 2019;9:157-171. https://doi.org/10.3233/JPD-181503
- Gratuze M, Josset N, Petry FR, Pflieger M, Jong LE, Truchetti G, et al. The toxin MPTP generates similar cognitive and locomotor deficits hTau and Tau knock-out mice. Brain Res 2019;1711:106-114. https://doi.org/10.1016/j.brainres.2019.01.016
- Love S, Jenner P. Oxidative stress in neurological disease. Brain Pathol 2006;9:55-56. https://doi.org/10.1111/j.1750-3639.1999.tb00210.x
- Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis 2013;3:461-491. https://doi.org/10.3233/JPD-130230
- Wi S, Lee JW, Kim M, Park CH, Cho SR. An enriched environment ameliorates oxidative stress and olfactory dysfunction in Parkinson's disease with α-synucleinopathy. Cell Transplant 2018;27:831-839. https://doi.org/10.1177/0963689717742662
- Hussain A, Pooryasin A, Zhang M, Loschek LF, Fortezza ML, Friedrich AB et al. Inhibition of Oxidative Stress in Cholinergic Projection Neurons Fully Rescues Aging-Associated Olfactory Circuit Degeneration in Drosophila. Elife 2018;10:32018.
- Stowe R, Ives N, Clarke CE, Deane K, van Hilten, Wheatley K et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications. Cochrane Database Syst Rev 2010;7:CD007166.
- Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653. https://doi.org/10.1002/mds.23429
- Fukaya C, Yamamoto T. Deep brain stimulation for Parkinson's disease: recent trends and future direction. Neurol Med Chir (Tokyo) 2015;55:422-431. https://doi.org/10.2176/nmc.ra.2014-0446
- Singh M, Girishan KV S, Bajaj J, Garg K. Deep brain stimulation for movement disorders: Surgical nuances. Neurol India 2018;66:122-130. https://doi.org/10.4103/0028-3886.226461
- Poewe W. Treatments for Parkinson disease-past achievements and current clinical needs. Neurology 2009;72:65-73. https://doi.org/10.1212/WNL.0b013e31819908ce
- Yu-Wai-Man P. Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol 2016;100:1322-1331. https://doi.org/10.1136/bjophthalmol-2015-308329
- Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e5836. https://doi.org/10.1097/MD.0000000000005836
- Xia Y, Wang HD, Ding Y, Kang B, Liu WG. Parkinson's disease combined with depression treated with electroacupuncture and medication and its effect on serum BDNF. Zhongguo Zhen Jiu 2012;32:1071-1074. [in Chiense].
- Arankalle DV, Nair PM. Effect of electroacupuncture on function and quality of life in Parkinson's disease: A case report. Acupunct Med 2013;31:235-238. https://doi.org/10.1136/acupmed-2012-010285
- Wang H, Pan Y, Xue B, Wang X, Zhao F, Jia J et al. The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease. PLoS One 2011;6:e19790. https://doi.org/10.1371/journal.pone.0019790
- Yu Y, Ju W, Li Z, Wang D, Wang Y, Xie A. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res 2010;1336:58-65. https://doi.org/10.1016/j.brainres.2010.04.020
- Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS et al. Acupuncture inhibits microglial activation and inflammatory events in the MPTP induced mouse model. Brain Res 2007;1131:211-219. https://doi.org/10.1016/j.brainres.2006.10.089
- Huo LR, Liang XB, Li B, Liang JT, He Y, Wang XM. The cortical and striatal gene expression profile of 100 Hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model. evid Based Complement Alternat Med 2012;2012:908439.
- Wayne PM, Manor B, Novak V, Costa MD, Hausdorff JM, Goldberger AL et al. A Systems Biology Approach to Studying Tai Chi, Physiological Complexity and Healthy Aging: Design and Rationale of a Pragmatic Randomized Controlled Trial. Contemp Clin Trials 2012;34:21-34.
- Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz G, Bonato GP et al. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord 2017;41:3-13. https://doi.org/10.1016/j.parkreldis.2017.05.019
- Liu XL, Chen S, Wang Y. Effects of health qigong exercises on relieving symptoms of Parkinson's disease. evid Based Complement Alternat Med 2016;2016:5935782.